2006

[44]

Novel inhibitors of the trypanosome alternative oxidase inhibit Trypanosoma brucei brucei growth and respiration. R. Ott, K. Chibale, S. Anderson, A. Chipeleme, M. Chaudhuri, A. Guerrah, N. Colowick, and G. C. Hill*. Acta Tropica, 2006, 100, 172-184.

[43]

Synthesis and Molecular Modeling of a Lisinopril-Tryptophan Analogue Inhibitor of Angiotensin I-Converting Enzyme. A. T. Nchinda, K. Chibale, P. Redelinghuys, and E. D. Sturrock*. Bioorg. Med. Chem Lett. 2006, 16, 4616-4619.

[42]

Synthesis of Novel Keto-ACE Analogues as Domain-Selective Angiotensin-I Converting Enzyme Inhibitors A. T. Nchinda, K. Chibale, P. Redelinghuys, and E. D. Sturrock*. Bioorg. Med. Chem Lett. 2006, 16, 4612-4615.

[41]

Dual-Acting Diamine Antiplasmodial and Chloroquine Resistance Modulating Agents. S. Yeh, P. J. Smith and K. Chibale* Biochemical Pharmacology 2006, 72, 156-165.

[40]

Application of Multi-Component Reactions to Antimalarial Drug Discovery. Part 2. New Antiplasmodial and Antitrypanosomal 4- Aminoquinoline γ- and δ Lactams via a “Catch and Release” Protocol. C. C. Musonda, J. Gut, P. J. Rosenthal V. Yardley, R. C. Carvalho de Souza and K. Chibale*. Bioorg. Med. Chem. 2006, 14, 5605-5615.

[39]

Novel approaches to antimalarial drug discovery. C. Biot*, and K. Chibale*. Infectious Disorders- Drug Targets-, 2006, 6, 173-204.

[38]

Novel Ketomethylene Inhibitors of Angiotensin-I Converting Enzyme (ACE): Inhibition and Molecular Modelling. P. Redelinghuys, A. T. Nchinda, K. Chibale and E. D. Sturrock*. Biological Chemistry, 2006, 387, 461-466.

[37]

Inhibitors of the trypanosome alternative oxidase reduce parasite growth in culture. R.D. Ott, K. Chibale, S. Anderson, A. Chipeleme, M. Chaudhuri, N. Colowick, and G. C. Hill. Faseb J., 2006, 20, A938-A938